Learn more

INTELLIGENT MED DEVICES INC

Overview
  • Total Patents
    38
  • GoodIP Patent Rank
    203,255
About

INTELLIGENT MED DEVICES INC has a total of 38 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, chemical engineering and organic fine chemistry are GENEOHM SCIENCES, CHEE MARK S and ZS GENETICS INC.

Patent filings per year

Chart showing INTELLIGENT MED DEVICES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jacobs Alice A 33
#2 Hully James R 26
#3 Leslin Chesley 21
#4 Dolinger David L 17
#5 Slater Damien 15
#6 Anzola Juan Manuel 10
#7 Reiske Heinz R 9
#8 Reiske Heinz 7
#9 Lauzier William 7
#10 Dolinger David 6

Latest patents

Publication Filing date Title
WO2014137906A1 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec a
WO2014066749A2 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b and respiratory syncytial virus
WO2013148868A1 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of herpes simplex virus
EP2729584A2 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b and respiratory syncytial virus
WO2012138470A2 Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group b streptococcus
WO2012078773A2 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec a
US2011256537A1 Optimized oligonucleotides and methods of using same for the screening, detection, isolation, quantitation, monitoring and sequencing of prostate cancer associated viruses and host biomarkers
CA2814762A1 Oligonucleotides relating to clostridium difficile genes encoding toxin b, toxin a, or binary toxin
WO2011035322A2 Probes and primers for binding, detecting, differentiating, isolating and sequencing of influenza a strains
WO2012047189A2 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers and the antibiotic resistance gene mec a
US2011200995A1 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci
WO2010151771A2 Optimized oligonucleotides and methods of using same for the detection, isolation, quantification, monitoring and sequencing of bordetella
WO2010135514A2 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
US2010173797A1 Devices and methods for diagnosis of susceptibility to diseases and disorders
EP2240503A2 Optimized probes and primers and method of using same for the detection of herpes simplex virus
AU2006320541A1 Methods and systems for designing primers and probes
CA2764288A1 Clinically intelligent diagnostic devices and methods